IMRX · Immuneering Corp
$5.21
+0.15 (+2.96%)
At close · Aug 17
Market Cap
$327.37M
Shares
64.70M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding IMRX
40 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Growth Company Fund | — | 2,943,677 | $16,985,016 | 0.02% | Long | 2026-05-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 1,623,577 | $8,556,251 | 0.00% | Long | 2026-03-31 | |
| Select Biotechnology Portfolio | — | 1,095,798 | $6,322,754 | 0.12% | Long | 2026-05-31 | |
| Fidelity Growth Company K6 Fund | — | 828,054 | $4,777,872 | 0.02% | Long | 2026-05-31 | |
| Fidelity Series Growth Company Fund | — | 719,805 | $4,153,275 | 0.02% | Long | 2026-05-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 691,472 | $3,644,057 | 0.03% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 624,026 | $3,288,617 | 0.03% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 614,250 | $3,237,098 | 0.00% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 390,008 | $2,055,342 | 0.03% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 281,673 | $1,625,253 | 0.00% | Long | 2026-05-31 | |
| iShares Micro-Cap ETF | — | 132,641 | $699,018 | 0.06% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 103,064 | $594,679 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 82,291 | $474,819 | 0.00% | Long | 2026-05-31 | |
| Large-Cap Growth Portfolio | — | 76,219 | $380,333 | 0.03% | Long | 2026-06-30 | |
| Ultra-Small Company Fund | — | 60,000 | $316,200 | 0.37% | Long | 2026-03-31 | |
| Avantis U.S. Small Cap Equity ETF | — | 52,296 | $301,748 | 0.01% | Long | 2026-05-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 51,854 | $273,271 | 0.04% | Long | 2026-03-31 | |
| Ultra-Small Company Market Fund | — | 49,849 | $262,704 | 0.21% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 41,005 | $236,599 | 0.00% | Long | 2026-05-31 | |
| LVIP State Street Small-Cap Index Fund | — | 39,700 | $198,103 | 0.01% | Long | 2026-06-30 | |
| Schwab Total Stock Market Index Fund | — | 37,344 | $195,683 | 0.00% | Long | 2026-04-30 | |
| VANGUARD BALANCED INDEX FUND | — | 29,577 | $155,871 | 0.00% | Long | 2026-03-31 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 20,937 | $110,338 | 0.00% | Long | 2026-03-31 | |
| Health Sciences Trust | — | 17,357 | $91,471 | 0.04% | Long | 2026-03-31 | |
| Range Cancer Therapeutics ETF | ABUF | 54,838 | $90,483 | 1.01% | Long | 2025-02-28 | |
| Small-Cap Index Portfolio | — | 15,410 | $76,896 | 0.01% | Long | 2026-06-30 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 12,686 | $66,855 | 0.04% | Long | 2026-03-31 | |
| 1290 VT Micro Cap Portfolio | — | 9,501 | $50,070 | 0.03% | Long | 2026-03-31 | |
| Guardian Large Cap Fundamental Growth VIP Fund | — | 9,722 | $48,513 | 0.03% | Long | 2026-06-30 | |
| U.S. SMALL CAP PORTFOLIO | — | 7,614 | $39,897 | 0.00% | Long | 2026-04-30 | |
| AVIP Fidelity Institutional AM Equity Growth Portfolio | — | 6,769 | $35,673 | 0.02% | Long | 2026-03-31 | |
| Victory Extended Market Index Fund | — | 5,983 | $31,351 | 0.00% | Long | 2026-04-30 | |
| PD Small-Cap Value Index Portfolio | — | 4,360 | $21,756 | 0.02% | Long | 2026-06-30 | |
| Invesco Nasdaq Biotechnology ETF | — | 3,407 | $19,658 | 0.03% | Long | 2026-05-31 | |
| Dimensional U.S. Core Equity 2 ETF | — | 3,598 | $18,854 | 0.00% | Long | 2026-04-30 | |
| ProShares Ultra Nasdaq Biotechnology | — | 2,387 | $13,773 | 0.02% | Long | 2026-05-31 | |
| Small-Cap Equity Portfolio | — | 2,468 | $12,315 | 0.00% | Long | 2026-06-30 | |
| Total Stock Market Index Trust | — | 1,093 | $5,760 | 0.00% | Long | 2026-03-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 500 | $2,635 | 0.00% | Long | 2026-03-31 | |
| State Street Balanced Index Fund | — | 372 | $1,960 | 0.00% | Long | 2026-03-31 |
Showing 1–40 of 40 positions
Key facts
CIK
1790340
CUSIP
45254E107
13F (30d)
108 filings
106 filers
Visit website
Investor relations